🇺🇸 FDA
Patent

US 10385070

Chroman-spirocyclic piperidine amides as modulators of ion channels

granted A61PA61P1/02A61P1/04

Quick answer

US patent 10385070 (Chroman-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/14, A61P1/16